对COVID-19患者TAFI水平和预后之间的关系的评估
概括
血清血栓激活纤维解酶抑制剂 (TAFI) 水平在严重的COVID-19病例中较高,与死亡率和输管相关. TAFI可能作为2019年冠状病毒病患者的预后生物标志物.
科学领域:
- 生物化学 生物化学
- 关键护理医学 关键护理医学
- 传染性疾病 传染性疾病
背景情况:
- 冠状病毒疾病2019 (COVID-19) 呈现出广泛的临床严重程度.
- 预后生物标志物对于管理COVID-19患者和预测结果至关重要.
- 热血素激活纤维解酶抑制剂 (TAFI) 在凝血和纤维解酶系统中起作用.
研究的目的:
- 为了研究COVID-19患者的血清血栓激活纤维解酶抑制剂 (TAFI) 水平.
- 确定血清TAFI水平与COVID-19中的疾病严重程度,死亡率和输管率之间的关系.
主要方法:
- 90名COVID-19患者被分为轻度,中度和重度组.
- 测量了血清中C反应蛋白,乳酸脱酶,纤维素,D-二聚合物,费里丁和TAFI的水平.
- 进行了统计分析,包括单向ANOVA和ROC曲线分析.
主要成果:
- 在疾病严重程度组之间观察到血清TAFI水平的显著差异 (p < 0.05).
- 严重的COVID-19病例与轻度病例相比,TAFI水平显著更高 (853.04±338.58与548.33±264.17 ng/mL).
- ROC分析表明,TAFI水平可以预测死亡率 (85%的检测) 和输管 (86%的检测).
结论:
- 血清TAFI水平升高与COVID-19中更严重的疾病进展有关.
- 高水平的TAFI与增加的死亡率和输管率有显著的相关性.
- 需要进一步的研究来确定血清TAFI作为COVID-19可靠的预后生物标志物.
更多相关视频
08:05Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
14.2K
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
2.0K
相关概念视频
01:21Acute Respiratory Failure-II
291
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
291
01:30Acute Coronary Syndrome III: Diagnostic Studies
12
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
12
01:30Pneumonia III: Complications and Assessment
289
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
289
01:30Acute Respiratory Failure-III
237
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
237
01:21Acute Respiratory Failure-I
256
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
256
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
15
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
15